Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 128 articles:
HTML format
Text format



Single Articles


    February 2019
  1. WANG X, Shen N, Lu Y, Tan K, et al
    Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease.
    Neurosci Lett. 2019 Feb 11. pii: S0304-3940(19)30101.
    PubMed     Text format     Abstract available


  2. GUNAYDIN C, Avci B, Bozkurt A, Onger ME, et al
    Effects of Agomelatine in Rotenone-induced Parkinson's Disease in Rats.
    Neurosci Lett. 2019 Feb 1. pii: S0304-3940(19)30075.
    PubMed     Text format     Abstract available


    January 2019
  3. KAWAMURA M, Sato S, Matsumoto G, Fukuda T, et al
    Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Neurosci Lett. 2019 Jan 23. pii: S0304-3940(19)30054.
    PubMed     Text format     Abstract available


    December 2018
  4. CAO Z, Wu Y, Liu G, Jiang Y, et al
    alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2018;696:114-120.
    PubMed     Text format     Abstract available


  5. WANG S, Li N, Zou H, Wu M, et al
    Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Neurosci Lett. 2018 Dec 17. pii: S0304-3940(18)30866.
    PubMed     Text format     Abstract available


  6. BUENO MEB, do Nascimento Neto LI, Terra MB, Barboza NM, et al
    Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson's disease.
    Neurosci Lett. 2018;696:46-51.
    PubMed     Text format     Abstract available


  7. ALIZADEH R, Kamrava SK, Bagher Z, Farhadi M, et al
    Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Neurosci Lett. 2018;696:52-59.
    PubMed     Text format     Abstract available


    November 2018
  8. LEVY-GIGI E, Haim-Nahum S, Hall JM, Crouse J, et al
    The interactive effect of valence and context on reversal learning in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Nov 6. pii: S0304-3940(18)30751.
    PubMed     Text format     Abstract available


    October 2018
  9. MIRANDA-MORALES EG, Sandoval-Carrillo A, Castellanos-Juarez FX, Mendez-Hernandez EM, et al
    H1/H2 MAPT haplotype and Parkinson's Disease in Mexican mestizo population.
    Neurosci Lett. 2018 Oct 16. pii: S0304-3940(18)30705.
    PubMed     Text format     Abstract available


  10. PURCARO C, Vanacore N, Moret F, Di Battista ME, et al
    DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30697.
    PubMed     Text format     Abstract available


  11. SHISHIDO T, Nagano Y, Araki M, Kurashige T, et al
    Synphilin-1 has neuroprotective effects on MPP(+)-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30696.
    PubMed     Text format     Abstract available


  12. FONSECA-FONSECA LA, Wong-Guerra M, Ramirez-Sanchez J, Montano-Peguero Y, et al
    JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Oct 7. pii: S0304-3940(18)30678.
    PubMed     Text format     Abstract available


    September 2018
  13. JIN L, Wan W, Wang L, Wang C, et al
    Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression.
    Neurosci Lett. 2018 Sep 19. pii: S0304-3940(18)30640.
    PubMed     Text format     Abstract available


  14. LU J, Chen S, Shen M, He Q, et al
    Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
    Neurosci Lett. 2018 Sep 18. pii: S0304-3940(18)30637.
    PubMed     Text format     Abstract available


  15. CACABELOS R
    Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Neurosci Lett. 2018 Sep 17. pii: S0304-3940(18)30624.
    PubMed     Text format     Abstract available


  16. CRUZ CF, Piemonte MEP, Okai-Nobrega LA, Okamoto E, et al
    Parkinson's disease does not alter automatic visual-motor coupling in postural control.
    Neurosci Lett. 2018;686:47-52.
    PubMed     Text format     Abstract available


    August 2018
  17. CHOI DJ, Kwon JK, Joe EH
    A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3.
    Neurosci Lett. 2018;685:144-149.
    PubMed     Text format     Abstract available


  18. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Text format     Abstract available


    July 2018
  19. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Text format     Abstract available


  20. GE F, Ding J, Liu Y, Lin H, et al
    Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: a meta-analysis.
    Neurosci Lett. 2018 Jul 20. pii: S0304-3940(18)30503.
    PubMed     Text format     Abstract available


  21. ROSAS-HERNANDEZ H, Chigurupati S, Raymick J, Robinson B, et al
    Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
    Neurosci Lett. 2018;687:1-9.
    PubMed     Text format     Abstract available


  22. SI QQ, Yuan YS, Zhi Y, Tong Q, et al
    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neurosci Lett. 2018;684:42-46.
    PubMed     Text format     Abstract available


    June 2018
  23. MARTIN-RODRIGUEZ JF, Mir P
    Short-afferent inhibition and cognitive impairment in Parkinson's disease: A Quantitative Review and Challenges.
    Neurosci Lett. 2018 Jun 27. pii: S0304-3940(18)30451.
    PubMed     Text format     Abstract available


  24. SHEN YT, Li JY, Yuan YS, Wang XX, et al
    Disrupted amplitude of low-frequency fluctuations and causal connectivity in Parkinson's disease with apathy.
    Neurosci Lett. 2018;683:75-81.
    PubMed     Text format     Abstract available


  25. LUCA A, Nicoletti A, Mostile G, Sciacca G, et al
    Temperament Traits And Executive Functions In Parkinson's Disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30443.
    PubMed     Text format     Abstract available


  26. LUOMA J, Pekkonen E, Airaksinen K, Helle L, et al
    Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30444.
    PubMed     Text format     Abstract available


  27. KWIATEK-MAJKUSIAK J, Geremek M, Koziorowski D, Tomasiuk R, et al
    Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.
    Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434.
    PubMed     Text format     Abstract available


  28. DU G, Zhuang P, Zhang Y, Li J, et al
    Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease.
    Neurosci Lett. 2018;683:1-6.
    PubMed     Text format     Abstract available


  29. PING Z, Xiaomu W, Xufang X, Wenfeng C, et al
    GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease.
    Neurosci Lett. 2018 Jun 7. pii: S0304-3940(18)30416.
    PubMed     Text format     Abstract available


  30. NAGARAJAN VB, Marathe PA
    Effect of montelukast in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Jun 6. pii: S0304-3940(18)30403.
    PubMed     Text format     Abstract available


    May 2018
  31. SHU L, Zhang Y, Sun Q, Pan H, et al
    SNCA REP1 and Parkinson's disease.
    Neurosci Lett. 2018 May 30. pii: S0304-3940(18)30394.
    PubMed     Text format     Abstract available


  32. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Text format     Abstract available


  33. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Text format     Abstract available


    April 2018
  34. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Text format     Abstract available


  35. WANG P, Guo Y, Song C, Liu Y, et al
    PINK1 p.K520RfsX3 Mutation Identified in a Chinese Family with Early-onset Parkinson's disease.
    Neurosci Lett. 2018 Apr 12. pii: S0304-3940(18)30283.
    PubMed     Text format     Abstract available


  36. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Text format     Abstract available


  37. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Text format     Abstract available


    March 2018
  38. CROOKS SA, Bech S, Halling J, Christiansen DH, et al
    Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
    Neurosci Lett. 2018;675:116-119.
    PubMed     Text format     Abstract available


  39. LI W, Jiang Y, Wang Y, Yang S, et al
    MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Neurosci Lett. 2018;675:83-88.
    PubMed     Text format     Abstract available


  40. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Text format     Abstract available


  41. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Text format     Abstract available


  42. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Text format     Abstract available


  43. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Text format     Abstract available


  44. WATANABE T, Saito K, Ishida K, Tanabe S, et al
    Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.
    Neurosci Lett. 2018 Mar 17. pii: S0304-3940(18)30209.
    PubMed     Text format     Abstract available


  45. POCHMANN D, Peccin PK, da Silva IRV, Dorneles GP, et al
    Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: A pilot study.
    Neurosci Lett. 2018 Mar 11. pii: S0304-3940(18)30190.
    PubMed     Text format     Abstract available


  46. JIN H, Chen J, Li K, Zhang JR, et al
    A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Neurosci Lett. 2018 Mar 9. pii: S0304-3940(18)30186.
    PubMed     Text format     Abstract available


    February 2018
  47. GUO T, Guan X, Zeng Q, Xuan M, et al
    Correlations between CSF proteins and spontaneous neuronal activity in Parkinson's disease.
    Neurosci Lett. 2018;673:61-66.
    PubMed     Text format     Abstract available


  48. DUTTA P, Dargahi L, O'Connell KE, Bolia A, et al
    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease.
    Neurosci Lett. 2018;673:12-18.
    PubMed     Text format     Abstract available


  49. DI NATALE C, Monaco A, Pedone C, Tessitore A, et al
    THE LEVEL OF 24-HYDROXYCHOLESTERYL ESTERS DECREASES IN PLASMA OF PATIENTS WITH PARKINSON'S DISEASE.
    Neurosci Lett. 2018 Feb 24. pii: S0304-3940(18)30123.
    PubMed     Text format     Abstract available


  50. JIANG X, Wang X, Tuo M, Ma J, et al
    RAGE and its emerging role in the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2018 Feb 22. pii: S0304-3940(18)30131.
    PubMed     Text format     Abstract available


  51. ZHENG X, Chen X, Guo M, Ali S, et al
    Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Neurosci Lett. 2018 Feb 15. pii: S0304-3940(18)30100.
    PubMed     Text format     Abstract available


  52. GOMEZ G, Saborido MD, Bernardi MA, Gershanik OS, et al
    Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Neurosci Lett. 2018;666:5-10.
    PubMed     Text format     Abstract available


  53. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Text format     Abstract available


    January 2018
  54. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Text format     Abstract available


  55. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Text format     Abstract available


  56. MOON HC, Won SY, Kim EG, Kim HK, et al
    Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-alpha-synuclein-induced hemiparkinson rat model.
    Neurosci Lett. 2018;662:129-135.
    PubMed     Text format     Abstract available


  57. ZHENG Q, Huang C, Guo J, Tan J, et al
    Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1.
    Neurosci Lett. 2018;662:264-270.
    PubMed     Text format     Abstract available


    December 2017
  58. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Text format     Abstract available


  59. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Text format     Abstract available


  60. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Text format     Abstract available


  61. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Text format     Abstract available


  62. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Text format     Abstract available


  63. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Text format     Abstract available


    November 2017
  64. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Text format     Abstract available


  65. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Text format     Abstract available


  66. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Text format     Abstract available


  67. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Text format     Abstract available


  68. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Text format     Abstract available


    October 2017
  69. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Text format     Abstract available


  70. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Text format     Abstract available


  71. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Text format     Abstract available


    September 2017
  72. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Text format     Abstract available


  73. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Text format     Abstract available


  74. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Text format     Abstract available


  75. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Text format     Abstract available


  76. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Text format     Abstract available


    August 2017
  77. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Text format     Abstract available


  78. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Text format     Abstract available


  79. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Text format     Abstract available


  80. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Text format     Abstract available


  81. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Text format     Abstract available


  82. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Text format     Abstract available


  83. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Text format     Abstract available


  84. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Text format     Abstract available


  85. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Text format     Abstract available


  86. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Text format     Abstract available


    July 2017
  87. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Text format     Abstract available


  88. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Text format     Abstract available


  89. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Text format     Abstract available


  90. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Text format     Abstract available


  91. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Text format     Abstract available


    June 2017
  92. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Text format     Abstract available


  93. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Text format     Abstract available


  94. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Text format     Abstract available


  95. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Text format     Abstract available


    May 2017
  96. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Text format     Abstract available


    April 2017
  97. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Text format     Abstract available


  98. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Text format     Abstract available


  99. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Text format     Abstract available


    March 2017
  100. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available


  101. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


  102. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


  103. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    February 2017
  104. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Text format     Abstract available


  105. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available


  106. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available


  107. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available


  108. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  109. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


  110. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    January 2017
  111. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Text format     Abstract available


  112. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Text format     Abstract available


  113. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Text format     Abstract available


  114. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Text format     Abstract available


    December 2016
  115. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Text format     Abstract available


  116. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Text format     Abstract available


  117. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Text format     Abstract available


    November 2016
  118. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Text format     Abstract available


  119. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Text format     Abstract available


  120. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Text format     Abstract available


    October 2016
  121. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Text format     Abstract available


  122. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Text format     Abstract available


  123. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Text format     Abstract available


  124. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Text format     Abstract available


    September 2016
  125. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Text format     Abstract available


  126. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Text format     Abstract available


  127. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Text format     Abstract available


  128. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: